Variables | Group I (n = 49) | Group II(n = 71) | Group III(n = 28) | P-value |
---|---|---|---|---|
Age, mean ± SD, years | 48.20 ± 16.44 | 44.58 ± 14.48 | 46.00 ± 11.78 | 0.417 |
Gender, male (n, %) | 32(65.3%) | 47(66.2%) | 23(82.1%) | 0.243 |
Weight, mean ± SD, Kg | 60.596 ± 11.1665 | 57.757 ± 10.9580 | 60.346 ± 11.2328 | 0.340 |
Length of first hospital stay days, median (IQR), days | 25(20–34.5) | 43(29–62) | 50.5(43–77.5) |  < 0.001* |
Admission time (n, %), years |  < 0.001* | |||
 2011–2015 | 0(0%) | 24(33.8%) | 21(75.0%) | |
 2016–2020 | 49(100%) | 47(66.2%) | 7(25.0%) | |
Underlying diseases (n, %) | ||||
 autoimmune disorder | 7(14.3%) | 6(8.5%) | 0(0%) | 0.104 |
 immunosuppressive agent | 8(16.3%) | 7(9.9%) | 1(3.6%) | 0.213 |
 diabetes mellitus | 6(12.2%) | 5(7.0%) | 0(0%) | 0.135 |
 liver cirrhosis | 0(0%) | 2(2.8%) | 1(3.6%) | 0.428 |
 Altered mental state (n, %) | 5(10.2%) | 7(9.9%) | 6(21.4%) | 0.257 |
BMRC stage (n, %) | 0.632 | |||
 1 | 0(0%) | 2(2.8%) | 0(0%) | |
 2 | 42(85.7%) | 60(85.4%) | 22(78.6%) | |
 3 | 7(14.3%) | 9(12.7%) | 6(21.4%) | |
CSF opening pressure, median (IQR), mmH2O | 240(147.5–330) | 266(175–330) | 280(162.75–330) | 0.311 |
CSF opening pressure >  = 200 (n, %) | 31(63.3%) | 51(71.8%) | 18(64.3%) | 0.565 |
CSF cryptococci, median (IQR), count/ml | 56(0–5718) | 1296(56–5376) | 505(17.25–4308.75) | 0.254 |
CSF white blood cell, median (IQR), *10^6/l | 120(47.5–185) | 120(64–190) | 106.5(34.5–241.5) | 0.671 |
CSF protein, median (IQR), g/l | 0.817(0.565–1.362) | 0.818(0.56–1.25) | 0.655(0.4125–0.9825) | 0.133 |
CSF glucose, median (IQR), mmol/l | 1.86(0.73–2.775) | 1.33(0.71–2.31) | 1.935(1.0825–2.665) | 0.366 |
CSF chloride, median (IQR), mmol/l | 116.8(110.8–121.15) | 116(109.4–119.3) | 117.5(113.35–120.95) | 0.158 |